Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Trend Edge Setup Score
Trend Edge rates ADMA Bearish with a Setup Score of 34, net conviction 30, actionability 38. How the Setup Score works →
Total Setup Score
34
Directional Bias
Bearish
Net Conviction
30
Actionability
38 (in range)
Key signals behind this score
40wk Downtrend — falling+below (sma 12.57 vs px 9.55)
Fresh Breakdown — 80wk turn 22w+40wk turn 32w
80wk Downtrend — falling+below (sma 15.22 vs px 9.55)
Funds Distributing — momZ +1.32 · 3.92→3.65
Short Attack — velZ +1.22 · age 103w×0.45 · 10.60%
Seasonal Headwind — september med -6.3% (mag 2/3) · posClose 25.00% (rel 2/3) · n12 ×1 = 11
RS Breakdown — momZ +1.08 · low 13w×1.00 · vs industry
About ADMA Biologics Inc
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodef… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: October 17, 2013
Headquarters: 465 State Route 17, Ramsey, NJ, United States, 07446
Founder-Led: Yes — Adam Grossman (Co-Founder, President, CEO & Director)
Key Metrics
Current Price
$9.72
Market Cap
$2.19B
Float
219.7M
Shares Outstanding
224.0M
P/E (Forward)
12.74
P/E (TTM)
13.94
Price/Sales (TTM)
4.27
vs. Analyst Target
+74.9% to analyst PT
Profit Margin
32.98%
Operating Margin (TTM)
-123.39%
Revenue (TTM)
$512M
Earnings Growth (YoY)
-52.80%
Dividend Rate
None
Analyst Target Price
$17.00 (3 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$42.2M
-$75.7M
-$19.1M
-$59.8M
2021
$80.9M
-$71.6M
$1.2M
-$53.1M
2022
$154M
-$65.9M
$35.3M
-$39.5M
2023
$258M
-$28.2M
$88.9M
$5.1M
2024
$426M
$198M
$220M
$148M
2025
$510M
$147M
$293M
$198M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Sep 2025
$134M
$36.4M
Dec 2025
$139M
$49.4M
Mar 2026
$114M
$45.3M
Jun 2026
$124M
$37.8M
Ownership & Float
Insider Ownership
2.0%
Institutional Ownership
93.3%
Short Float
10.0%
% of All Funds Holding
3.65%
Number of Funds Holding
321
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$9.12
Near-term / short-term trend
Weekly
40-Week SMA
$12.58
Medium-term trend
Weekly
80-Week SMA
$15.22
Cyclical trend (business cycle)
Weekly
200-Week SMA
$10.96
Secular trend (multi-year)
Monthly
10-Month SMA
$12.41
Near-term monthly trend
Monthly
20-Month SMA
$15.22
Medium-term monthly trend
Monthly
40-Month SMA
$12.07
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$10.20
resistance
1.46x
2 months ago
$15.70
resistance
2.56x
4 months ago
Historical Earnings Reactions (52 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
0.35%
0.27%
51.92%
23.87%
-25.35%
1 Day
1.92%
0.53%
53.85%
30.93%
-19.80%
1 Week
2.12%
0.89%
55.77%
43.97%
-22.19%
2 Weeks
5.24%
2.64%
55.77%
50.94%
-25.28%
1 Month
5.65%
2.76%
54.90%
55.56%
-35.81%
Next earnings: October 24, 2026 (58 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
2.7%
46.2%
13
Feb
-1.8%
46.2%
13
Mar
5.8%
53.8%
13
Apr
2.6%
61.5%
13
May
3.9%
61.5%
13
Jun
-3.5%
30.8%
13
Jul
9.1%
76.9%
13
Aug
-0.2%
25.0%
12
Sep
-2.1%
25.0%
12
Oct
-2.6%
50.0%
12
Nov
8.1%
61.5%
13
Dec
-5.8%
30.8%
13
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
0.11%
44.8%
607
Tuesday
0.13%
44.3%
666
Wednesday
-0.08%
45.5%
661
Thursday
-0.15%
43.9%
649
Friday
0.43%
49.0%
647
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 93.3%
Insider Transactions — Smart Summary
Total insider ownership: 2.0%
Founder-led management: Adam Grossman (Co-Founder, President, CEO & Director)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for ADMA Biologics Inc
(ADMA) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.